Study title: A multicenter, open-label, single-dose study to evaluate the pharmacokinetics (i.e. 24 hour pharmacokinetic sampling period) of valsartan given as an oral suspension in pediatric patients 1 year to 16 years of age with hypertension.
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: VALSARTAN | |||||
| ATC code: | |||||
| Document link: EMA spreadsheet_Diovan_CVAL489A2305_2.xls | |||||
| Document date: 2013-10-04 | |||||
| Study number: CVAL489A2305 | |||||
| EudraCT number: | |||||
| Scope of study: CLINICAL | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | - | - | |